Blockchain Registration Transaction Record

Creative Biolabs Links Glycoprotein Development with Glycan Analysis

Creative Biolabs integrates glycoprotein development with glycan characterization, offering carbohydrate and monosaccharide analysis to support therapeutic glycoprotein research.

This news matters because glycosylation is a critical quality attribute that can affect the safety, efficacy, and stability of therapeutic glycoproteins. By integrating development and characterization, Creative Biolabs is helping researchers move beyond a one-size-fits-all approach to glycan analysis. The ability to tailor analytical strategies to specific molecules and research questions can lead to more efficient development, better understanding of production-related variation, and ultimately more robust biotherapeutics. As the biopharmaceutical industry continues to advance complex glycoprotein drugs, access to comprehensive glycan characterization services will be essential for ensuring product consistency and meeting regulatory expectations.